Processing

Please wait...

Settings

Settings

1. WO2007115821 - ORGANIC COMPOUNDS

Publication Number WO/2007/115821
Publication Date 18.10.2007
International Application No. PCT/EP2007/003185
International Filing Date 10.04.2007
IPC
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
211
Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
04
with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
06
having no double bonds between ring members or between ring members and non-ring members
08
with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
18
with substituted hydrocarbon radicals attached to ring carbon atoms
26
with hydrocarbon radicals, substituted by nitrogen atoms
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
211
Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
92
with a hetero atom directly attached to the ring nitrogen atom
96
Sulfur atom
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
471
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/-C07D463/251
02
in which the condensed system contains two hetero rings
08
Bridged systems
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
439
the ring forming part of a bridged ring system, e.g. quinuclidine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3
Drugs for disorders of the metabolism
08
for glucose homeostasis
10
for hyperglycaemia, e.g. antidiabetics
C07D 211/26 (2006.01)
C07D 211/96 (2006.01)
C07D 471/08 (2006.01)
A61K 31/439 (2006.01)
A61P 3/10 (2006.01)
CPC
C07D 211/26
C07D 211/96
C07D 471/08
Applicants
  • NOVARTIS AG [CH/CH]; Lichtstrasse 35 CH-4056 Basel, CH (AllExceptUS)
  • BAESCHLIN, Daniel, Kaspar [CH/CH]; CH (UsOnly)
  • FENTON, Garry [GB/GB]; GB (UsOnly)
  • NAMOTO, Kenji [JP/CH]; CH (UsOnly)
  • OSTERMANN, Nils [DE/DE]; DE (UsOnly)
  • SEDRANI, Richard [LU/CH]; CH (UsOnly)
  • SIROCKIN, Finton [FR/FR]; FR (UsOnly)
Inventors
  • BAESCHLIN, Daniel, Kaspar; CH
  • FENTON, Garry; GB
  • NAMOTO, Kenji; CH
  • OSTERMANN, Nils; DE
  • SEDRANI, Richard; CH
  • SIROCKIN, Finton; FR
Agents
  • LIGIBEL, Jean-Marc; Novartis AG Corporate Intellectual Property CH-4002 Basel, CH
Priority Data
0607309.211.04.2006GB
06122445.717.10.2006EP
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) ORGANIC COMPOUNDS
(FR) COMPOSÉS ORGANIQUES
Abstract
(EN)
The present invention relates to compounds of the formula; and their use in therapy.
(FR)
La présente invention concerne des composés répondant à la formule ; et leur utilisation en thérapie.
Latest bibliographic data on file with the International Bureau